Compositions and methods for processing sperm

Patent metadata

Field	Value
Publication number	US-9347040-B2
Application number	US-201313844636-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	Jun 1, 2011
Publication date	May 24, 2016
Grant date	May 24, 2016

Abstract

The present invention relates to compositions and methods for the handling of processed sperm including samples that are freshly collected, those transported as fresh samples, samples that are frozen and thawed, those sorted into one or more subpopulations, and those that are otherwise processed or handled that impose trauma on the cell. Trauma can reduce the motility, fertility, viability and overall integrity of the sperm and reduce the ability to fertilize, produce an embryo and a healthy offspring. The present invention relates to novel compounds that can be added to the sperm cell sample to reduce the traumatic effects of physical stress during mild as well as extensive sperm cell processing, methods of using the compounds in standard sperm processing procedures, the end products made from these methods including sperm and embryos, as well as methods of using those end products in assisted reproductive biology techniques in animals.

First claim

The invention claimed is:

1. A method of producing an embryo using assisted reproductive technologies (ART) by reducing stress on a sperm cell during sperm processing, comprising:
a) forming a sperm cell composition by adding vitamin B12 or a vitamin B12 vitamer-to a sperm cell sample, wherein the added vitamin B12 or B12 vitamer is at a final concentration range of 0.01 to 1 mg/ml in the sperm cell composition,
b) holding the sperm cell composition for a period of time,
c) processing the sperm cell composition to form a processed sperm cell composition, and
d) using the processed sperm cell composition in ART.

2. The method as claimed in claim 1 , wherein the ART is selected from the group consisting of: in vitro fertilization (IVF), artificial insemination (AI), intracytoplasmic sperm injection (ICSI), multiple ovulation and embryo transfer (MOET).

3. The method as claimed in claim 1 , wherein the assisted reproductive technique is in vitro fertilization (IVF), or multiple ovulation and embryo transfer (MOET).

4. The method as claimed in claim 1 , wherein the final concentration of the added vitamin B12 or vitamin B12 vitamer is selected from the group consisting of 0.05 mg/ml, 0.1 mg/ml, 0.25 mg/m, 0.35 mg/ml, 0.45 mg/ml, and 0.5 mg/ml.

5. The method as claimed in claim 1 , wherein the final concentration of the added vitamin B12 or vitamin B12 vitamer is 0.15 mg/ml, 0.1 mg/ml, 0.25 mg/ml or 0.35 mg/ml.

6. The method as claimed in claim 1 , wherein processing the sperm cell composition comprises two or more processing steps selected from the group consisting of: holding; transporting; buffering; chilling; warming; staining; diluting; concentrating; exciting with a laser; electronic charging; deflecting; ablating; sorting; collecting; shaking; oscillating; magnetically separating; oxygenating; labeling; precipitating; centrifuging; resuspending; mixing; dialyzing; cryostabilizing; freezing; thawing; vitrifying; culturing; inseminating; microinjecting; microfluidic processing; microchip processing; jet and air processing; and flow cytometry processing.

7. The method as claimed in claim 1 , wherein processing constitutes two or more processing steps and wherein vitamin B12, or vitamin B12 vitamer, is added at multiple sperm cell processing steps prior to or during use in ART.

8. A method as claimed in claim 2 wherein the in vitro fertilization comprises mixing one or more eggs with the sperm cell composition in the presence of vitamin B12 or vitamin B12 vitamer.

9. The method as claimed in claim 1 , wherein the sperm cell sample is unfrozen.

10. The method as claimed in claim 1 , wherein the sperm cell sample is frozen.

11. The method as claimed in claim 1 , wherein the processed sperm cell composition is unfrozen.

12. The method as claimed in claim 1 , wherein the processed sperm cell composition is frozen.

13. The method as claimed in claim 1 , wherein the sperm cell sample is obtained from a human, a bovine, a ovine, an equine, an deer, an elk, a buffalo, a canine, a feline, a chimpanzee, a gorilla, a whale, a dolphin or other marine mammal.

14. The method as claimed in claim 1 , wherein the sperm cell sample has been sorted.

15. The method as claimed in claim 14 , wherein the sperm cell sample has been gender sorted.

16. The method as claimed in claim 14 , wherein the sorted sperm were processed using a multi-step processing procedure with the addition of vitamin B12, or a vitamin B12 vitamer, at one or more processing steps.

17. The method as claimed in claim 1 , wherein the vitamin B12, or vitamin B12 vitamer, is added at a final concentration of 0.25 mg/ml in the sperm cell composition.

18. The method as claimed in claim 1 , further comprising adding alpha-ketoglutarate to the sperm cell composition at a final concentration in the range of 0.25 to 0.45 mg/ml in the sperm cell composition.

Assignees

• Inguran Llc

Inventors

• Lenz Richard
• Moreno Juan
• Vishwanath Ramakrishnan

Classifications

• A61P15/00

  Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives · CPC title

• C12N5/0609 Primary

  Oocytes, oogonia (fertilised oocytes C12N5/0604) · CPC title

• C12N2502/04

  germ cells · CPC title

• C12N2500/30

  Organic components · CPC title

• G01N15/1459

  the analysis being performed on a sample stream · CPC title